Outstanding Outcome for Children with Standard Risk-Low (SR-Low) Acute Lymphoblastic Leukemia (ALL) and No Benefit to Intensified Peg-Asparaginase (PEG-ASNase) Therapy: Results of Children's Oncology Group (COG) Study AALL0331

被引：0
|
作者：
Mattano, Leonard A. [1 ]
Devidas, Meenakshi [2 ]
Friedmann, Alison M. [3 ]
Raetz, Elizabeth A. [4 ]
Loh, Mignon [5 ]
Buckley, Patrick [6 ]
Borowitz, Michael J. [7 ]
Carroll, Andrew J. [8 ]
Gastier-Foster, Julie [9 ]
Heerema, Nyla A. [10 ]
Kadan-Lottick, Nina [11 ]
Matloub, Yousif [12 ]
Marshall, David T. [13 ]
Stork, Linda C. [14 ]
Wood, Brent L. [15 ]
Winick, Naomi J. [16 ]
Hunger, Stephen [17 ,18 ]
Carroll, William L. [19 ]
Maloney, Kelly [20 ]
机构：
[1] Bronson Methodist Hosp, Kalamazoo, MI USA
[2] Univ Florida, Gainesville, FL USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] Primary Childrens Med Ctr, Salt Lake City, UT USA
[5] Dept Pediat Hematol Oncol, San Francisco, CA USA
[6] Duke Univ, Med Ctr, Durham, NC USA
[7] Johns Hopkins Univ, Baltimore, MD USA
[8] Univ Alabama Birmingham, Birmingham, AL USA
[9] Nationwide Childrens Hosp, Columbus, OH USA
[10] Ohio State Univ, Columbus, OH 43210 USA
[11] Yale Univ, Sch Med, New Haven, CT USA
[12] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA
[13] Med Univ S Carolina, Charleston, SC 29425 USA
[14] OR Hlth Sci Univ, Portland, OR USA
[15] Seattle Canc Care Alliance, Seattle, WA USA
[16] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[17] Univ Colorado, Sch Med, Aurora, CO USA
[18] Childrens Hosp, Aurora, CO USA
[19] NYU, Langone Med Ctr, New York, NY USA
[20] Childrens Hosp Colorado, Aurora, CO USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Impact of 6 Mercaptopurine (6MP) Pill-Taking Habits on Adherence, Thioguanine Nucleotide (TGN) Levels and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): Results from a Children's Oncology Group (COG) Study (AALL03N1)
    Hageman, Lindsey
    Landier, Wendy
    Chen, Yanjun
    Kim, Heeyoung
    Kornegay, Nancy
    Evans, William E.
    Bostrom, Bruce C.
    Casillas, Jacqueline
    Dickens, David
    Angiolillo, Anne
    Lew, Glen
    Maloney, Kelly
    Mascarenhas, Leo
    Ritchey, Arthur K.
    Termuhlen, Amanda
    Carroll, William L.
    Relling, Mary V.
    Wong, F. Lennie
    Bhatia, Smita
    BLOOD, 2014, 124 (21)
  • [42] Incidence of adverse reactions to post-induction asparaginase (ASP) therapy in children and adolescents with high-risk acute lymphoblastic leukemia (ALL): A report from the Children's Oncology Group Study CCG-1961
    Dhall, G.
    Robison, N. J.
    Rubin, J. I.
    Sather, H. N.
    Gaynon, P. S.
    Seibel, N. L.
    Ettinger, L. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] Improved Post-Induction Chemotherapy Does Not Abrogate Prognostic Significance of Minimal Residual Disease (MRD) for Children and Young Adults with High Risk Acute Lymphoblastic Leukemia (ALL). A Report From Children's Oncology Group (COG) Study AALL0232
    Borowitz, Michael J.
    Wood, Brent L.
    Devidas, Meenakshi
    Loh, Mignon L.
    Raetz, Elizabeth A.
    Salzer, Wanda
    Nachman, James
    Carroll, Andrew J.
    Heerema, Nyla A.
    Gastier-Foster, Julie M.
    Willman, Cheryl L.
    Linda, Stephen B.
    Winick, Naomi
    Hunger, Stephen
    Carroll, William L.
    Larsen, Eric C.
    BLOOD, 2011, 118 (21) : 625 - 626
  • [44] Escalating Dose Intravenous Methotrexate without Leucovorin Rescue during Interim Maintenance Is Superior to Oral Methotrexate for Children with Standard Risk Acute Lymphoblastic Leukemia (SR-ALL): Children's Oncology Group Study 1991
    Matloub, Yousif
    Bostrom, Bruce C.
    Hunger, Stephen P.
    Angiolillo, Anne L.
    Cole, Catherine
    Thomson, Blythe
    Devidas, Meenakshi
    Heerema, Nyla A.
    La, Mei K.
    Buckley, Patrick J.
    Carroll, William L.
    Winick, Naomi
    Sather, Harland
    Nachman, James B.
    Gaynon, Paul S.
    BLOOD, 2008, 112 (11) : 9 - 10
  • [45] A Pilot Study of Azacitidine As Epigenetic Priming for Chemotherapy in Infants Less Than 1 Year of Age with KMT2A-Rearranged Acute Lymphoblastic Leukemia (ALL); Results from the Children's Oncology Group (COG) Trial AALL15P1
    Guest, Erin
    Kairalla, John
    Devidas, Meenakshi
    Hibbitts, Emily
    Carroll, Andrew J.
    Heerema, Nyla A.
    Kubaney, Holly
    August, Amanda
    Pauly, Melinda
    Wechsler, Daniel
    Miles, Rodney R.
    Reid, Joel M.
    Kihei, Cynthia
    Gore, Lia
    Raetz, Elizabeth A.
    Hunger, Stephen P.
    Loh, Mignon L.
    Brown, Patrick A.
    BLOOD, 2022, 140 : 3256 - 3257
  • [46] A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in Low Risk (LR) First Relapse of B -Acute Lymphoblastic Leukemia (B-ALL) in Children and Adolescents/Young Adults (AYAs): A Report from Children's Oncology Group Study AALL1331
    Brown, Patrick A.
    Ji, Lingyun
    Xu, Xinxin
    Devidas, Meenakshi
    Hogan, Laura E.
    Borowitz, Michael J.
    Raetz, Elizabeth A.
    Zugmaier, Gerhard
    Sharon, Elad
    Bernhardt, Melanie B.
    Terezakis, Stephanie A.
    Gore, Lia
    Whitlock, James A.
    Pulsipher, Michael A.
    Hunger, Stephen P.
    Loh, Mignon L.
    BLOOD, 2021, 138
  • [47] Outcome in adolescent and young adult (AYA) patients compared with younger patients treated for high-risk B-precursor acute lymphoblastic leukemia (HR-ALL): A report from the Children's Oncology Group study AALL0232
    Larsen, Eric
    Raetz, Elizabeth A.
    Winick, Naomi Joan
    Salzer, Wanda L.
    Nachman, James B.
    Devidas, Meenakshi
    Hunger, Stephen
    Carroll, William L.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] Identification of Novel Cluster Groups in High-Risk Pediatric B-Precursor Acute Lymphoblastic Leukemia (HR-ALL) by Gene Expression Profiling: Correlation with Clinical and Outcome Variables. a Children's Oncology Group (COG) Study
    Harvey, Richard C.
    Chen, I-Ming
    Ar, Kerem
    Hunger, Stephen P.
    Loh, Mignon
    Larsen, Eric C.
    Devidas, Meenakshi
    Raetz, Elizabeth
    Reaman, Gregory
    Carroll, William L.
    Winick, Naomi
    Smith, Malcolm
    Dobbin, Kevin K.
    Willman, Cheryl L.
    BLOOD, 2008, 112 (11) : 787 - 787
  • [49] Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group
    Matloub, Yousif
    Lindemulder, Susan
    Gaynon, Paul S.
    Sather, Harland
    La, Mei
    Broxson, Emmett
    Yanofsky, Rochelle
    Hutchinson, Raymond
    Heerema, Nyla A.
    Nachman, James
    Blake, Marilyn
    Wells, Linda M.
    Sorrell, April D.
    Masterson, Margaret
    Kelleher, John F.
    Stork, Linda C.
    BLOOD, 2006, 108 (04) : 1165 - 1173
  • [50] Anti-Pegaspargase, Anti-Calaspargase Pegol, and Anti-Polyethelene Glycol Antibody Incidence in High Risk Acute Lymphoblastic Leukemia Patients Receiving Pegaspargase or Calaspargase Pegol and Associated Anaphylactic or Hypersensitivity Reaction Rates: Results from Children's Oncology Group (COG) Study AALL07P4
    Schore, Reuven J.
    Devidas, Meenakshi
    Bleyer, Archie
    Reaman, Gregory
    Lebedinsky, Claudia
    Zhang, Hui
    Koppensteiner, Herwig
    Loh, Mignon L.
    Raetz, Elizabeth
    Winick, Naomi
    Carroll, William L.
    Hunger, Stephen P.
    Angiolillo, Anne
    BLOOD, 2016, 128 (22)
12345